ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BXP Beximco Pharma

33.50
0.00 (0.00%)
25 Nov 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Beximco Pharma LSE:BXP London Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 33.50 33.00 34.00 33.50 33.50 33.50 113,608 00:00:00

Beximco Pharma Discussion Threads

Showing 1976 to 1998 of 2225 messages
Chat Pages: 89  88  87  86  85  84  83  82  81  80  79  78  Older
DateSubjectAuthorDiscuss
17/1/2022
12:15
Dividend not paid in ii yet

Good increase today!

Long term hold for me

fegger
15/1/2022
14:53
I'm looking back at that chart at 120p and thinking. Why didn't I reduce my holding?
3800
14/1/2022
20:52
Suspect we might look back on this retrace and think, why oh why didn't we buy more.....
microscope
13/1/2022
20:05
A five-day course of Beximco’s Bexovid costs around $190 at drug stores at Dhaka.

At some pharmacies in Dhaka it immediately sold out.

Sohag Babu, a salesman at Lazz Pharma, one of the largest drug chain shops in the capital, said the store had sold its supplies as soon as it received them: “It just came to the market two days ago. We immediately received queries from customers.”

While Bangladesh is not experiencing a surge of COVID-19 infections now, a new viral wave is expected to hit the country in the next few months. The availability of the new drug raises hopes that the country would be able to save more people from the disease.

stav13
13/1/2022
19:17
Does seem ridiculous. I was trying to find the XD date, (not when credited). Wonder if it was this week which might explain a few short-sighted sellers.
microscope
13/1/2022
18:26
I don't understand why this has pulled back. Now on ttm p/e of less than 11. Growth looks set to continue, and I think these are a bargain. I've been thinking of reducing my emerging market exposure, but not much else here I don't like
leopoldalcox
13/1/2022
17:46
Anyone know when dividend will be paid?
neil1pat
05/1/2022
10:39
SYME is about to multibag
charlescharliesback
04/1/2022
22:30
US doubles orders of Pfizer's Paxlovid to 20 million...


"Big order for Pfizer's antiviral pill

It comes as the US doubled its order for Pfizer's oral COVID-19 antiviral treatment.

The drugs maker and the White House said 20 million courses of Paxlovid would now be procured - with four million ready by the end of January..."




Bodes well for BXP's generic version...

"30 December 2021

BEXIMCO PHARMACEUTICALS LTD.

Beximco Pharma introduces world's first generic version of Pfizer's Paxlovid, the first US FDA approved oral therapy for COVID-19 treatment"

someuwin
04/1/2022
09:14
Difficult to buy any.
someuwin
03/1/2022
20:28
Hmm... I'm still sitting on these... :o)

A buyout would still be nice, hopefully for £3+.

In the meantime more sitting... be interesting to see how much cash they might make from Bexovid.... £3 might come quicker.

I like this share because I just leave it alone and it drifts up.

So we have a 179p prediction and that was before the recent RNS. :o)

GLA

greg the grinch
01/1/2022
09:38
Yesterday the UK approved the Pfizer pill for those with weakened immune systems, and I'd expect to see a tidal wave of further approvals globally in the coming weeks to try and keep pace with Omicron, and any future, variants.

Obviously producing the world's first generic version puts Beximco right at the forefront of the fight against Covid.

Also great point about the likelihood of BXP producing a vaccine, toadhall.

HNY all! :)

microscope
31/12/2021
12:31
We have another iron in the fire to stimulate interest. Just wait till the Co announces a plan to produce vaccines (non Covid / and possibly Covid). See the 24 th Nov RNS. No smoke without fire.
toadhall1
31/12/2021
10:19
I'm sure India in particular, with its population of about 1.4 billion, will be casting glances in Beximco's direction.

Given the huge problems India has had with the Delta variant, and the fact that they provided Beximco with many millions of vaccines, further co-operation between the two would seem a logical step.

microscope
31/12/2021
08:54
Nice write-up in The Times Market Report this morning. Here is an extract:

Beximco Pharmaceuticals quick off the mark with clone of Pfizer’s antiviral drug

"It’s been quite a year for listed pharmaceutical companies. Many have been at the forefront of the fight against coronavirus, rushing to produce vaccines in record time and in turn helping reopen economies across the world.

One of those is Beximco Pharmaceuticals. The first Bangladeshi company to float on London’s junior stock market in 2005 makes cheap versions of patented drugs for sale in some of the world’s poorest countries.

Its shares, which are up just over 10 per cent on this time last year, got a further boost yesterday after it launched what it claimed to be the world’s first generic version of Pfizer’s Covid-19 treatment Paxlovid.

Last week the US Food and Drug Administration approved Pfizer’s antiviral pill after it proved nearly 90 per cent effective in preventing hospital admissions and deaths in high-risk patients.

Beximco said it plans to launch its own version in Bangladesh under the name Bexovid. The news sent the shares to a record high, closing up 2½p, or 2.3 per cent, at 111p."

jim208
30/12/2021
15:17
.....Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company"), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces the launch of the world's first generic version of Pfizer's COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir tablets, co-packaged for oral use) which was granted emergency use authorization (EUA) by the US FDA on 22 December 2021. Directorate General of Drug Administration (DGDA), Bangladesh, has today granted EUA for the oral antiviral drug to treat mild-to-moderate COVID-19 in adults and children of 12 years and above. This novel antiviral pill showed almost 90% efficacy in preventing hospitali z ations and deaths in high-risk patients, and recent data from Pfizer suggests the drug retains its effectiveness against the fast-spreading Omicron variant of the coronavirus. Beximco Pharma will market this product under the brand name Bexovid, initially in Bangladesh.
davebowler
30/12/2021
12:40
What an announcement!

World's first generic version of Pfizer pill.

If this was a better known pharma market reaction would be off the scale.

Quiet time generally for market news, hopefully we'll get very decent press coverage.

Fantastic yield, chart breakout too, profitable and low enough p/e!

For anybody who's not seen this....

microscope
30/12/2021
11:14
On dividend payment questions, the company did drop an RNS on Christmas Eve to say that it will be paid on or before the 20th January. My past experience is that it can take time to filter into accounts, so it may need some patience.
jim208
30/12/2021
11:07
great RNS today IMO.

Hopefully, BXP can roll this out to other countries outside of Bangladesh.

mfhmfh
21/12/2021
16:20
Sorry - Stocko's changed the payment date to 1/1/22
podgyted
21/12/2021
16:16
When is the dividend due to be paid - haven't rec'd mine yet
podgyted
10/12/2021
13:22
Dave - thanks for that
cb7
24/11/2021
21:03
A small rise on today's vaccine media comment. Patience needed.
Put in the drawer and come back late next year.

outsizeclothes.com
Chat Pages: 89  88  87  86  85  84  83  82  81  80  79  78  Older

Your Recent History

Delayed Upgrade Clock